Home
Storia in 1 fonti
Cipla is aiming for 40-50 global product filings in three years, says MD Achin Gupta
Cipla is charting its next growth phase with a strong focus on innovation, complex generics, and biosimilars. The company plans significant global product filings over the next three years. Cipla will also expand its presence in North America and Europe. Innovation is expected to contribute a meaningful portion of revenues in the coming decade.
Raccontata da
economictimes.indiatimes.com
Timeline cronologica
- ·
Innovation, biosimilars, complex generics to drive Cipla's growth: Achin Gupta, MD & Group CEO
As Cipla approaches its centenary, the company is redefining its strategy by prioritizing innovation to amplify revenues. With ambitions to broaden its footprint in North America…
- ·
Innovation, biosimilars, complex generics to drive Cipla's growth: Achin Gupta, MD & Goup CEO
As Cipla approaches its centenary, the company is redefining its strategy by prioritizing innovation to amplify revenues. With ambitions to broaden its footprint in North America…
- ·
Cipla is aiming for 40-50 global product filings in three years, says MD Achin Gupta
Cipla is charting its next growth phase with a strong focus on innovation, complex generics, and biosimilars. The company plans significant global product filings over the next…